| Year |
Citation |
Score |
| 2014 |
Okon L, Rosenbach M, Krathen M, Rose M, Propert K, Okawa J, Werth V. Lenalidomide in treatment-refractory cutaneous lupus erythematosus: Efficacy and safety in a 52-week trial. Journal of the American Academy of Dermatology. 70: 583-4. PMID 24528907 DOI: 10.1016/J.Jaad.2013.11.007 |
0.356 |
|
| 2014 |
Yang W, Propert KJ, Richard Landis J. Estimating the efficacy of an interstitial cystitis/painful bladder syndrome medication in a randomized trial with both non-adherence and loss to follow-up. Statistics in Medicine. 33: 3547-55. PMID 23225539 DOI: 10.1002/Sim.5702 |
0.316 |
|
| 2012 |
FitzGerald MP, Payne CK, Lukacz ES, Yang CC, Peters KM, Chai TC, Nickel JC, Hanno PM, Kreder KJ, Burks DA, Mayer R, Kotarinos R, Fortman C, Allen TM, Fraser L, ... ... Propert KJ, et al. Randomized multicenter clinical trial of myofascial physical therapy in women with interstitial cystitis/painful bladder syndrome and pelvic floor tenderness. The Journal of Urology. 187: 2113-8. PMID 22503015 DOI: 10.1016/J.Juro.2012.01.123 |
0.301 |
|
| 2011 |
Yang CC, Burks DA, Propert KJ, Mayer RD, Peters KM, Nickel JC, Payne CK, FitzGerald MP, Hanno PM, Chai TC, Kreder KJ, Lukacz ES, Foster HE, Cen L, Landis JR, et al. Early termination of a trial of mycophenolate mofetil for treatment of interstitial cystitis/painful bladder syndrome: lessons learned. The Journal of Urology. 185: 901-6. PMID 21238993 DOI: 10.1016/J.Juro.2010.10.053 |
0.3 |
|
| 2010 |
Pontari MA, Krieger JN, Litwin MS, White PC, Anderson RU, McNaughton-Collins M, Nickel JC, Shoskes DA, Alexander RB, O'Leary M, Zeitlin S, Chuai S, Landis JR, Cen L, Propert KJ, et al. Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial. Archives of Internal Medicine. 170: 1586-93. PMID 20876412 DOI: 10.1001/Archinternmed.2010.319 |
0.303 |
|
| 2010 |
Foster HE, Hanno PM, Nickel JC, Payne CK, Mayer RD, Burks DA, Yang CC, Chai TC, Kreder KJ, Peters KM, Lukacz ES, FitzGerald MP, Cen L, Landis JR, Propert KJ, et al. Effect of amitriptyline on symptoms in treatment naïve patients with interstitial cystitis/painful bladder syndrome. The Journal of Urology. 183: 1853-8. PMID 20303115 DOI: 10.1016/J.Juro.2009.12.106 |
0.323 |
|
| 2010 |
Payne C, Fitzgerald MP, Burks D, Nickel JC, Lukacz E, Kreder K, Chai T, Hanno P, Mayer R, Yang C, Peters K, Foster H, Landis JR, Cen L, Propert K, et al. 1035 RANDOMIZED MULTICENTER CLINICAL TRIAL SHOWS EFFICACY OF MYOFASCIAL PHYSICAL THERAPY IN WOMEN WITH INTERSTITIAL CYSTITIS/PAINFUL BLADDER SYNDROME (IC/PBS) Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.2113 |
0.307 |
|
| 2008 |
Propert KJ, Mayer R, Nickel JC, Payne CK, Peters KM, Teal V, Burks D, Kusek JW, Nyberg LM, Foster HE. Followup of patients with interstitial cystitis responsive to treatment with intravesical bacillus Calmette-Guerin or placebo. The Journal of Urology. 179: 552-5. PMID 18082224 DOI: 10.1016/J.Juro.2007.09.035 |
0.338 |
|
| 2008 |
Shoskes DA, Berger R, Elmi A, Landis JR, Propert KJ, Zeitlin S. Muscle tenderness in men with chronic prostatitis/chronic pelvic pain syndrome: the chronic prostatitis cohort study. The Journal of Urology. 179: 556-60. PMID 18082223 DOI: 10.1016/J.Juro.2007.09.088 |
0.304 |
|
| 2007 |
Keay S, Reeder JE, Koch K, Zhang CO, Grkovic D, Peters K, Zhang Y, Kusek JW, Nyberg LM, Payne CK, Propert KJ. Prospective evaluation of candidate urine and cell markers in patients with interstitial cystitis enrolled in a randomized clinical trial of Bacillus Calmette Guerin (BCG). World Journal of Urology. 25: 499-504. PMID 17694391 DOI: 10.1007/S00345-007-0205-4 |
0.317 |
|
| 2007 |
Propert KJ, Mayer R, Nickel JC, Payne CK, Peters KM, Teal V, Burks D, Kusek JW, Nyberg LM, Foster HE. Did patients with interstitial cystitis who failed to respond to initial treatment with bacillus Calmette-Guerin or placebo in a randomized clinical trial benefit from a second course of open label bacillus Calmette-Guerin? The Journal of Urology. 178: 886-90. PMID 17631335 DOI: 10.1016/J.Juro.2007.05.052 |
0.307 |
|
| 2007 |
Lee SW, Cheah PY, Liong ML, Yuen KH, Schaeffer AJ, Propert K, Krieger JN. Demographic and clinical characteristics of chronic prostatitis: prospective comparison of the University of Sciences Malaysia Cohort with the United States National Institutes of Health Cohort. The Journal of Urology. 177: 153-7; discussion 15. PMID 17162027 DOI: 10.1016/J.Juro.2006.08.098 |
0.307 |
|
| 2006 |
Propert KJ, Litwin MS, Wang Y, Alexander RB, Calhoun E, Nickel JC, O'Leary MP, Pontari M, McNaughton-Collins M. Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) Quality of Life Research. 15: 299-305. PMID 16468084 DOI: 10.1007/S11136-005-1317-1 |
0.339 |
|
| 2006 |
Propert KJ, Mayer RD, Wang Y, Sant GR, Hanno PM, Peters KM, Kusek JW. Responsiveness of symptom scales for interstitial cystitis Urology. 67: 55-59. PMID 16413332 DOI: 10.1016/J.Urology.2005.07.014 |
0.316 |
|
| 2006 |
Propert KJ, McNaughton-Collins M, Leiby BE, O'Leary MP, Kusek JW, Litwin MS. A prospective study of symptoms and quality of life in men with chronic prostatitis/chronic pelvic pain syndrome: the National Institutes of Health Chronic Prostatitis Cohort study. The Journal of Urology. 175: 619-23; discussion 6. PMID 16407009 DOI: 10.1016/S0022-5347(05)00233-8 |
0.302 |
|
| 2005 |
Wu Y, Fedorov VV, Propert KJ. Optimal design for dose response using beta distributed responses. Journal of Biopharmaceutical Statistics. 15: 753-71. PMID 16078383 DOI: 10.1081/Bip-200067760 |
0.503 |
|
| 2005 |
Mayer R, Propert KJ, Peters KM, Payne CK, Zhang Y, Burks D, Culkin DJ, Diokno A, Hanno P, Landis JR, Madigan R, Messing EM, Nickel JC, Sant GR, Warren J, et al. A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis. The Journal of Urology. 173: 1186-91. PMID 15758738 DOI: 10.1097/01.Ju.0000152337.82806.E8 |
0.304 |
|
| 2005 |
Nickel JC, Wang Y, Shoskes D, Propert K. 106: Validation of the Pre and Post Massage Test (PPMT) for the Evaluation of the Patient with Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) The Journal of Urology. 173: 29-29. DOI: 10.1016/S0022-5347(18)34371-4 |
0.316 |
|
| 2004 |
Alexander RB, Propert KJ, Schaeffer AJ, Landis JR, Nickel JC, O'Leary MP, Pontari MA, McNaughton-Collins M, Shoskes DA, Comiter CV, Datta NS, Fowler JE, Nadler RB, Zeitlin SI, Knauss JS, et al. Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Annals of Internal Medicine. 141: 581-9. PMID 15492337 DOI: 10.7326/0003-4819-141-8-200410190-00005 |
0.316 |
|
| 2004 |
Alexander RB, Propert KJ, Schaeffer AJ, Landis JR, Kusek JW, Litwin MS. 232: A Randomized Trial of Ciprofloxacin and Tamsulosin in Men with Chronic Prostatitis/Chronic Pelvic Pain Syndrome Journal of Urology. 171: 61-61. DOI: 10.1016/S0022-5347(18)37494-9 |
0.313 |
|
| 2003 |
Leaf AN, Propert K, Corcoran C, Catalano PJ, Trump DL, Harris JE, Davis TE. Phase III study of combined chemohormonal therapy in metastatic prostate cancer (ECOG 3882): An eastern cooperative oncology group study Medical Oncology. 20: 137-145. PMID 12835516 DOI: 10.1385/Mo:20:2:137 |
0.357 |
|
| 2002 |
Schaeffer AJ, Knauss JS, Landis JR, Propert KJ, Alexander RB, Litwin MS, Nickel JC, O'Leary MP, Nadler RB, Pontari MA, Shoskes DA, Zeitlin SI, Fowler JE, Mazurick CA, Kusek JW, et al. Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study. The Journal of Urology. 168: 1048-53. PMID 12187220 DOI: 10.1016/S0022-5347(05)64572-7 |
0.302 |
|
| 2002 |
Coleman CN, Kelly L, Riese Daly N, Beard C, Kaplan I, Lamb C, Propert K, Manola J. Phase III study of ibuprofen versus placebo for radiation-induced genitourinary side effects. International Journal of Radiation Oncology, Biology, Physics. 54: 191-4. PMID 12182991 DOI: 10.1016/S0360-3016(02)02907-3 |
0.358 |
|
| 2002 |
Propert KJ, Alexander RB, Nickel JC, Kusek JW, Litwin MS, Landis JR, Nyberg LM, Schaeffer AJ. Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome. Urology. 59: 870-6. PMID 12031372 DOI: 10.1016/S0090-4295(02)01601-1 |
0.319 |
|
| 2001 |
Bruce Malkowicz S, McKenna WG, Vaughn DJ, Wan XS, Propert KJ, Rockwell K, Marks SHF, Wein AJ, Kennedy AR. Effects of Bowman-Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasia Prostate. 48: 16-28. PMID 11391683 DOI: 10.1002/Pros.1077 |
0.346 |
|
| 1999 |
Clark JA, Rieker P, Propert KJ, Talcott JA. Changes in quality of life following treatment for early prostate cancer Urology. 53: 161-168. PMID 9886606 DOI: 10.1016/S0090-4295(98)00457-9 |
0.323 |
|
| 1998 |
Coleman M, Rafla S, Propert KJ, Glicksman A, Peterson B, Nissen N, Brunner K, Holland JF, Anderson JR, Gottlieb A, Kaufman T. Augmented therapy of extensive Hodgkin's disease: Radiation to known disease or prolongation of induction chemotherapy did not improve survival- results of a cancer and leukemia group B study International Journal of Radiation Oncology Biology Physics. 41: 639-645. PMID 9635714 DOI: 10.1016/S0360-3016(98)00071-6 |
0.337 |
|
| 1998 |
Beard CJ, Lamb C, Buswell L, Schneider L, Propert KJ, Gladstone D, D'Amico A, Kaplan I. Radiation-associated morbidity in patients undergoing small-field external beam irradiation for prostate cancer International Journal of Radiation Oncology Biology Physics. 41: 257-262. PMID 9607338 DOI: 10.1016/S0360-3016(98)00054-6 |
0.356 |
|
| 1998 |
Berlin JD, Propert KJ, Trump D, Wilding G, Hudes G, Glick J, Burch P, Keller A, Loehrer P. 5-Fluorouracil and leucovorin therapy in patients with hormone refractory prostate cancer: an Eastern Cooperative Oncology Group phase II study (E1889). American Journal of Clinical Oncology. 21: 171-6. PMID 9537206 DOI: 10.1097/00000421-199804000-00016 |
0.369 |
|
| 1998 |
Talcott JA, Rieker P, Clark JA, Propert KJ, Weeks JC, Beard CJ, Wishnow KI, Kaplan I, Loughlin KR, Richie JP, Kantoff PW. Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 16: 275-83. PMID 9440753 DOI: 10.1200/Jco.1998.16.1.275 |
0.313 |
|
| 1997 |
Saxman SB, Propert KJ, Einhorn LH, Crawford ED, Tannock I, Raghavan D, Loehrer PJ, Trump D. Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: A cooperative group study Journal of Clinical Oncology. 15: 2564-2569. PMID 9215826 DOI: 10.1200/Jco.1997.15.7.2564 |
0.306 |
|
| 1997 |
Dreicer R, Propert KJ, Kuzel T, Kirkwood JM, O'Dwyer PJ, Loehrer PJ. A Phase II trial of edatrexate in patients with advanced renal cell carcinoma: An Eastern Cooperative Oncology Group Study American Journal of Clinical Oncology: Cancer Clinical Trials. 20: 251-253. PMID 9167747 DOI: 10.1097/00000421-199706000-00008 |
0.339 |
|
| 1997 |
Beard CJ, Propert KJ, Rieker PP, Clark JA, Kaplan I, Kantoff PW, Talcott JA. Complications after treatment with external-beam irradiation in early- stage prostate cancer patients: A prospective multiinstitutional outcomes study Journal of Clinical Oncology. 15: 223-229. PMID 8996146 DOI: 10.1200/Jco.1997.15.1.223 |
0.326 |
|
| 1997 |
Dreicer R, Propert KJ, Roth BJ, Einhorn LH, Loehrer PJ. Vinblastine, ifosfamide, and gallium nitrate - An active new regimen in patients with advanced carcinoma of the urothelium: A phase II trial of the eastern cooperative oncology group (E5892) Cancer. 79: 110-114. PMID 8988734 DOI: 10.1002/(Sici)1097-0142(19970101)79:1<110::Aid-Cncr16>3.0.Co;2-7 |
0.347 |
|
| 1993 |
Luikart SD, Goutsou M, Mitchell ED, Van Echo DA, Modeas CR, Propert KJ, O'Donnell J, Difino S, Perry MC, Green MR. Phase I/II trial of etoposide and carboplatin in extensive small-cell lung cancer American Journal of Clinical Oncology: Cancer Clinical Trials. 16: 127-131. PMID 8383914 DOI: 10.1097/00000421-199304000-00009 |
0.332 |
|
| 1992 |
Hargis JB, Anderson JR, Propert KJ, Green MR, Van Echo DA. Predicting genitourinary toxicity in patients receiving cisplatin-based combination chemotherapy: a cancer and leukemia group B study Cancer Chemotherapy and Pharmacology. 30: 291-296. PMID 1643697 DOI: 10.1007/Bf00686298 |
0.318 |
|
| 1992 |
Canellos GP, Anderson JR, Propert KJ, Nissen N, Cooper MR, Henderson ES, Green MR, Gottlieb A, Peterson BA. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD New England Journal of Medicine. 327: 1478-1484. PMID 1383821 DOI: 10.1056/Nejm199211193272102 |
0.341 |
|
| 1992 |
Green MR, Kreisman H, Doll DC, Lyss AP, Clamon GH, Goutsou M, Perry MC, Propert KJ. Carboplatin in non-small cell lung cancer: An update on the Cancer and Leukemia Group B experience Seminars in Oncology. 19: 44-49. PMID 1329222 DOI: 10.5555/Uri:Pii:009377549290007N |
0.342 |
|
| 1992 |
Lyss AP, Perry MC, Goutsou M, Propert K, Herndon JE, Mason-Coughlin K, Green MR. Intensive etoposide and carboplatin chemotherapy for advanced non-small-cell lung cancer. A phase II trial of the Cancer and Leukemia Group B. American Journal of Clinical Oncology. 15: 399-404. PMID 1326224 DOI: 10.1097/00000421-199210000-00003 |
0.353 |
|
| 1992 |
Citron ML, Modeas C, Propert K, Goutsou M, Green MR. Phase II trial of high-dose 24-hour continuous intravenous 5-fluorouracil for advanced non-small cell lung cancer: a Cancer and Leukemia Group B study. Cancer Investigation. 10: 215-9. PMID 1316201 DOI: 10.3109/07357909209032763 |
0.354 |
|
| 1990 |
Rybak ME, McCarroll K, Kaplan RJ, Propert KJ, Budman DR, Gottlieb AJ. Phase II trial of etoposide and cis-diaminodichloro-platinum in patients with refractory and relapsed Hodgkin's disease: Cancer and Leukemia Group B (CALGB) Study 8353. Medical and Pediatric Oncology. 18: 177-80. PMID 2329962 DOI: 10.1002/Mpo.2950180302 |
0.354 |
|
| 1990 |
Dillman RO, Seagren SL, Propert KJ, Guerra J, Eaton WL, Perry MC, Carey RW, Frei EF, Green MR. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer New England Journal of Medicine. 323: 940-945. PMID 2169587 DOI: 10.1056/Nejm199010043231403 |
0.336 |
|
| 1990 |
Ringenberg QS, Propert KJ, Muss HB, Weiss RB, Schilsky RL, Modeas C, Perry MC, Norton L, Green M. Clinical cardiotoxicity of esorubicin (4′-deoxydoxorubicin,DxDx): Prospective studies with serial gated heart scans and reports of selected cases - A Cancer and Leukemia Group B report Investigational New Drugs. 8: 221-226. PMID 2166722 DOI: 10.1007/Bf00177265 |
0.336 |
|
| 1990 |
Graziano SL, Lee K, Propert KJ, Tinsley R, Hayes DM, Green M, Comis RL. Phase II trial of etoposide and cisplatin for refractory small cell lung cancer: a Cancer and Leukemia Group B Study. Medical and Pediatric Oncology. 18: 22-6. PMID 2152956 DOI: 10.1002/Mpo.2950180105 |
0.356 |
|
| 1989 |
Chahinian AP, Propert KJ, Ware JH, Zimmer B, Perry MC, Hirsh V, Skarin A, Kopel S, Holland JF, Comis RL, Green MR. A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B Journal of Clinical Oncology. 7: 993-1002. PMID 2547030 DOI: 10.1200/Jco.1989.7.8.993 |
0.351 |
|
| 1988 |
Propert KJ, Anderson JR. Assessing the effect of toxicity on prognosis: Methods of analysis and interpretation Journal of Clinical Oncology. 6: 868-870. PMID 3367190 DOI: 10.1200/Jco.1988.6.5.868 |
0.315 |
|
| 1988 |
McIntyre OR, Tefft M, Propert K, Wolf DJ, Coleman M, Leone L, Cooper MR, Eaton W, Zimmer B. Melphalan and prednisone plus total bone marrow irradiation as initial treatment for multiple myeloma International Journal of Radiation Oncology Biology Physics. 15: 1007-1012. PMID 3182309 DOI: 10.1016/0360-3016(88)90139-3 |
0.324 |
|
| 1988 |
Ringenberg QS, Perry MC, Propert KJ, Modeas C, Hirsh V, Weiss RB, Richards F, Graziano S, Green M. Phase II trial of 4'-deoxydoxorubicin (DxDx) in non-small cell lung cancer: A cancer and leukemia group B trial Medical and Pediatric Oncology. 16: 27-29. PMID 2828901 DOI: 10.1002/Mpo.2950160107 |
0.302 |
|
| 1987 |
Perry MC, Eaton WL, Propert KJ, Ware JH, Zimmer B, Chahinian AP, Skarin A, Carey RW, Kreisman H, Faulkner C. Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung New England Journal of Medicine. 316: 912-918. PMID 3029592 DOI: 10.1056/Nejm198704093161504 |
0.329 |
|
| 1987 |
Choi NC, Propert K, Carey R, Eaton W, Leone LA, Silberfarb P, Green M. Accelerated radiotherapy followed by chemotherapy for locally recurrent small-cell carcinoma of the lung. A phase II study of Cancer and Leukemia Group B. International Journal of Radiation Oncology, Biology, Physics. 13: 263-6. PMID 3028996 DOI: 10.1016/0360-3016(87)90137-4 |
0.314 |
|
| 1987 |
Kwiatkowski DJ, Propert KJ, Carey RW, Choi N, Green M. A phase II trial of cyclophosphamide, etoposide, and cisplatin with combined chest and brain radiotherapy in limited small-cell lung cancer: A Cancer and Leukemia Group B study Journal of Clinical Oncology. 5: 1874-1879. PMID 2824709 DOI: 10.1200/Jco.1987.5.12.1874 |
0.317 |
|
| 1986 |
Cooper MR, McIntyre OR, Propert KJ, Kochwa S, Anderson K, Coleman M, Kyle RA, Prager D, Rafla S, Zimmer B. Single, sequential, and multiple alkylating agent therapy for multiple myeloma: A CALGB study Journal of Clinical Oncology. 4: 1331-1339. PMID 3528403 DOI: 10.1200/Jco.1986.4.9.1331 |
0.31 |
|
| 1986 |
Vinciguerra V, Propert KJ, Coleman M, Anderson JR, Stutzman L, Pajak TF, Nissen NI, Frizzera G, Gottlieb A, Holland JF. Alternating cycles of combination chemotherapy for patients with recurrent Hodgkin's disease following radiotherapy: A prospectively randomized study by the cancer and leukemia group B Journal of Clinical Oncology. 4: 838-846. PMID 2423652 DOI: 10.1200/Jco.1986.4.6.838 |
0.339 |
|
| Show low-probability matches. |